Key result
Neonatal ECMO shows ~3-fold higher thrombin-antithrombin levels by day 5, marking progressive coagulation activation.
Why the study?
Coagulation system activation during extracorporeal membrane oxygenation causes hemostatic derangements. This study sought to quantify the extent of hemostasis activation by measuring thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer.
Does extracorporeal membrane oxygenation increase activation markers of coagulation and fibrinolysis differently in neonates compared to children older than 30 days?
Cohort (n=29)
No
Does extracorporeal membrane oxygenation increase activation markers of coagulation and fibrinolysis differently in neonates compared to children older than 30 days?
Neonates on ECMO exhibit a persistent increase in coagulation activation despite unfractionated heparin anticoagulation, while fibrinolysis activation may contribute to bleeding in older children, suggesting anticoagulation protocols should be individualized by age.
Objective Coagulation system activation in extracorporeal membrane oxygenation results in hemostatic derangements. Thrombin generation markers like prothrombin fragment 1+2 and thrombin-antithrombin complex are sensitive markers of hypercoagulability. Plasmin-antiplasmin complex is a sensitive marker for fibrinolysis. D-dimers reflect thrombin generation and fibrinolysis. The aim was to identify the extent of hemostasis activation during extracorporeal membrane oxygenation by measuring thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer. Design Prospective cohort study. Setting Tertiary care academic center. Patients Children placed on extracorporeal membrane oxygenation from April 2011 to January 2013. Interventions Prothrombin fragment 1+2, thrombin-antithrombin complex, plasmin-antiplasmin complex, and D-dimer were measured on days 1 and 5 of extracorporeal membrane oxygenation. Measurements and main results Data presented as median (interquartile range); nonparametric tests were done using SPSS. Twenty-nine children (52% < 30 d old [neonates], median extracorporeal membrane oxygenation length 151 hr) were studied. Complications included thrombosis in 14%, bleeding in 45%, and thrombosis and bleeding together in 10%. Thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer levels were high on day 1 and remained increased on extracorporeal membrane oxygenation. In neonates, all levels were higher on day 5 compared with day 1: thrombin-antithrombin complex (55.6 μg/L [30.7-76.0] vs 18.7 μg/L [10.9-34.6]; p = 0.03), prothrombin fragment 1+2 (2,038 pmol/L [1,093-4,018.5] vs 377.5 pmol/L [334.3-1,103.0]; p = 0.00), plasmin-antiplasmin complex (2,160 μg/L [786-3,090] vs 398 μg/L [296.8-990.8]; p = 0.00), and D-dimer (3.0 μg/mL [1.9-11.5] vs 1.5 μg/mL [0.6-2.9]; p = 0.01). Thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer levels did not correlate with anti-Xa activity or heparin dose. In bleeders older than 30 days, plasmin-antiplasmin complex stayed elevated on day 5, but in patients with no bleeding complications, plasmin-antiplasmin level showed a declining trend. In neonates, plasmin-antiplasmin levels increased over the course of extracorporeal membrane oxygenation irrespective of bleeding. Conclusion Despite our best efforts at adequate anticoagulation with unfractionated heparin, neonates showed persistent increase in coagulation activation on extracorporeal membrane oxygenation. Fibrinolysis activation may contribute to bleeding in patients older than 30 days. Different anticoagulation protocols should be individualized based on age.
No takes yet. Share an insight, caveat, or question.
Hundalani et al. (2014) conducted a cohort in Hemostatic derangements in children on extracorporeal membrane oxygenation (n=29). Extracorporeal membrane oxygenation in neonates (<30 days old) vs. Day 1 vs Day 5 of extracorporeal membrane oxygenation (and children >30 days old) was evaluated on Thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer levels on days 1 and 5 (p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: